PULSE BIOSCIENCES, INC. Quarterly Costs and Expenses in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Pulse Biosciences, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2020 to Q3 2024.
  • Pulse Biosciences, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $13.7M, a 21.4% increase year-over-year.
  • Pulse Biosciences, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $48.5M, a 22% increase year-over-year.
  • Pulse Biosciences, Inc. annual Costs and Expenses for 2023 was $43.6M, a 25.8% decline from 2022.
  • Pulse Biosciences, Inc. annual Costs and Expenses for 2022 was $58.8M, a 8.81% decline from 2021.
  • Pulse Biosciences, Inc. annual Costs and Expenses for 2021 was $64.4M, a 29% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $48.5M $13.7M +$2.4M +21.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $46.1M $11.7M +$1.5M +14.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $44.6M $10.6M +$1.05M +11% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $43.6M $12.5M +$3.8M +43.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $39.8M $11.3M -$6.77M -37.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $46.6M $10.2M -$4.05M -28.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $50.6M $9.56M -$8.16M -46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $58.8M $8.74M -$7.52M -46.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $66.3M $18M +$3.18M +21.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $63.1M $14.3M -$527K -3.56% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $63.6M $17.7M -$808K -4.36% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $64.4M $16.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $14.8M +$1.94M +15% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $14.8M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $18.5M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $12.9M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.